Neuroleptic drugs
Kostowski, W.; Płaznik, A.
Wiadomosci Lekarskie 37(3): 233-236
1984
ISSN/ISBN: 0043-5147 PMID: 6147047 Document Number: 229003
Document emailed within 1 workday
Related Documents
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117Krzymiński, S. 1989: Neuroleptic drugs in geriatric psychiatry Psychiatria Polska 23(1): 36-43
Loewenguth, C.; D'Amato, T.; Dalery, J. 1996: Neuroleptic drugs. Principles and rules of use La Revue du Praticien 46(6): 745-752
Fukuda, T.; Tsumagari, T. 1984: Effects of psychotropic drugs on lateral hypothalamic self-stimulation behavior in rats: correlation between self-stimulation behavior inhibition and striatal dopaminergic blockade by neuroleptic drugs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(6): 485-496
Erenberg, G. 1992: Treatment of Tourette syndrome with neuroleptic drugs Advances in Neurology 58: 241-243
Lavie, C.J.; Ventura, H.O.; Walker, G. 1986: Neuroleptic malignant syndrome: three episodes with different drugs Southern Medical Journal 79(12): 1571-1573
Alderman, C.P.; Fraser, C.D. 1995: Use of risperidone with a patient sensitive to conventional neuroleptic drugs American Journal of Psychiatry 152(8): 1234-1235
Langer, G.; Sachar, E.J.; Gruen, P.H. 1978: Prolactin response to neuroleptic drugs in normal and schizophrenic subjects Psychopharmacology Bulletin 14(1): 8-9
Meltzer, H.Y.; Koenig, J.I.; Nash, J.F.; Gudelsky, G.A. 1989: Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs Acta Psychiatrica Scandinavica. Supplementum 352: 24-29
Georget, S.; Giesenfeld, A.; Gonzalvez, M.F.; Mangin, A.; Montaut, T.; Pareja, J.P.; Kahn, J.P. 1998: Survey of the quality of prescribing anticholinergic drugs in neuroleptic treated patients L'Encephale 24(2): 100-107
Sayed, Y.; Garrison, J.M. 1983: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review Psychopharmacology Bulletin 19(2): 283-288
Ben Hadj Ali, B.; Dogui, M.; Ben Ammou, S.; Lôo, H. 1995: Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal L'Encephale 21(3): 209-215
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148
McShane, R.; Keene, J.; Gedling, K.; Fairburn, C.; Jacoby, R.; Hope, T. 1997: Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up BMJ 314(7076): 266-270
Haas, H.G.; Kern, R.; Lack, E.G. 1971: The voltage-clamp technique as a tool for testing drugs: the antifibrillatory action of a neuroleptic agent (Droperidol) Arztliche Forschung 25(4): 110-125
Drtil, M.; Vinar, O.; Taussigová, D. 1973: Maintenance treatment with long-acting neuroleptic drugs in persons with disturbances of social behavior and drug dependence Activitas Nervosa Superior 15(2): 87
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Sindelár, K.; Metysová, J.; Protiva, M. 1973: A new group of highly potent neuroleptic drugs in the series of 10-piperazi nodibenzo (b,f) thiepins: 8-Acyl derivatives of perathiepin (chemistry and pharmacology) Activitas Nervosa Superior 15(2): 97-98
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374